Periocular allergic contact dermatitis associated with the use of ofloxacin ophthalmic ointment: A case report
- Authors
- Jo, J.W.; Jeong, H.B.; Shin, Y.B.; Kang, K.R.; Kim, C.Y.
- Issue Date
- 2018
- Publisher
- Korean Dermatological Association
- Keywords
- Allergic contact dermatitis; Ofloxacin; Ophthalmic ointment
- Citation
- Korean Journal of Dermatology, v.56, no.10, pp 624 - 627
- Pages
- 4
- Indexed
- SCOPUS
KCI
- Journal Title
- Korean Journal of Dermatology
- Volume
- 56
- Number
- 10
- Start Page
- 624
- End Page
- 627
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/13136
- ISSN
- 0494-4739
- Abstract
- Allergic contact dermatitis is an inflammatory condition associated with periorbital erythema, edema, and pruritus. The periorbital skin is relatively thin compared with the skin over other facial areas; therefore, it is vulnerable to allergen penetration and may show a variety of cutaneous manifestations. Recently, vision enhancement surgery is a widely performed procedure, and the prevalence of senile cataract and glaucoma is increasing. The prevalence of periocular allergic contact dermatitis is increasing secondary to the growing use of topical ophthalmic medications. Several studies in Korea have reported periocular allergic contact dermatitis secondary to the use of topical ophthalmic medications including latanoprost (Latano®), fluorometholone (Tolon®), polymyxin B (Terramycin®), atropine sulfate (Atropine®), neomycin sulfate (Cambison®), and befunolol hydrochloride (Bentos®), among others. However, ofloxacin (Effexin®)-induced allergic contact dermatitis has not been reported in the domestic and/or foreign literature. We report a case of periocular allergic contact dermatitis secondary to the use of ofloxacin ophthalmic ointment. ? 2018 GSK group of companies or its licensor.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.